Wolverine Trading, LLC Arvinas, Inc. Put Options Transaction History

Wolverine Trading, LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$23.66 - $32.73 $78,078 - $108,008	3,300 Added 36.26%	12,400 $305,000
Q2 2024 Aug 14, 2024	SELL	$24.46 - $40.4 $51,366 - $84,840	-2,100 Reduced 18.75%	9,100 $242,000
Q1 2024 May 15, 2024	BUY	$36.38 - $52.31 $61,846 - $88,927	1,700 Added 17.89%	11,200 $462,000
Q4 2023 Feb 14, 2024	BUY	$14.19 - $42.33 $134,805 - $402,135	9,500 New	9,500 $391,000
Q2 2023 Aug 23, 2023	BUY	$21.73 - $31.43 $191,224 - $276,584	8,800 New	8,800 $218,000
Q4 2022 Feb 14, 2023	BUY	$32.47 - $57.24 $529,261 - $933,012	16,300 New	16,300 $558,000
Q2 2021 Aug 06, 2021	SELL	$60.45 - $84.26 $314,340 - $438,152	-5,200 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$58.19 - $91.37 $302,588 - $475,124	5,200 New	5,200 $325,000

229

68.4M

226K

285K

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $1.21B
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.